ALC:NYSE
Alcon
74,11 $
arrow_upward
+0,64%(+0,47) 1D
74,98 $
arrow_upward
+1,17% (+0,87)bedtimeAfter hours
Closed: 17 նոյ, 16:00:03 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ALC...
Open
73,40 $
High
74,54 $
Low
73,36 $
Mkt. cap
30,88 մլրդ
Avg. vol.
2,15 մլն
Volume
4,80 մլն
52-wk high
87,64 $
52-wk low
61,84 $
Beta
0,87
Shares outstanding
483,40 մլն
No. of employees
25 հզր
Open
73,40 $
High
74,54 $
Low
73,36 $
Mkt. cap
30,88 մլրդ
Avg. vol.
2,15 մլն
Volume
4,80 մլն
52-wk high
87,64 $
52-wk low
61,84 $
Beta
0,87
Shares outstanding
483,40 մլն
No. of employees
25 հզր
News stories
From web sources and news partners
TradingView
·
1 ժամ առաջ
S&P 500, Dow, Nasdaq Futures Power Ahead On Nvidia Outlook Beat — NVDA, TSLA, ANT In Focus
BigGo Finance
·
3 ժամ առաջ
Wall Street Split on 2027 S&P 500 Outlook: Wells Fargo's 8,200 vs. Morgan Stanley's 8,700
ChartMill
·
3 ժամ առաջ
S&P 500 After-Hours Gainers for Nov. 17, 2026
Traders Union
·
22 րոպե առաջ
S&P 500 rises 10 percent amid challenging backdrop, Nate Geraci notes
Profile
Alcon Inc. is a Swiss-American pharmaceutical and medical device company specializing in eye care products. Alcon is incorporated in the Canton of Fribourg, Switzerland, and its global headquarters are located in Geneva, but its main operational base is in Fort Worth, Texas, United States, where it employs about 4,500 people.
Alcon was a subsidiary of Novartis until April 2019, when it was spun out into a separate publicly traded company. Alcon itself has a number of subsidiaries, including Aerie Pharmaceuticals, focused on therapies for glaucoma and other diseases of the eye, and WaveLight, which develops and manufactures laser eye surgery technologies. Wikipedia
About Alcon
CEODavid J. Endicott
Employees25 հզր
Founded1945
HeadquartersԺնև, Ժնև, Շվեյցարիա
SectorHealth Care
Industry-
Websitealcon.com